Califf cautions against lowering FDA standards; Editas outlines $1B milestone package
→ Ex-FDA Commissioner Robert Califf is back at Duke. And he has some advice for the Trump administration as it follows through on plans …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
